Traumatic brain injury therapeutics pipeline assessment and market forecasts to 2019

343 views
299 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
343
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Traumatic brain injury therapeutics pipeline assessment and market forecasts to 2019

  1. 1. Traumatic Brain Injury Therapeutics - Pipeline Assessment and MarketForecasts to 2019GlobalData, the industry analysis specialist, has released its new report, “Traumatic BrainInjury Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is anessential source of information and analysis on the global Traumatic Brain InjuryTherapeutics market. The report identifies the key trends shaping and driving the globalTraumatic Brain Injury Therapeutics market. The report also provides insights on theprevalent competitive landscape and the emerging players expected to significantly alterthe market positioning of the current market leaders. Most importantly, the reportprovides valuable insights on the pipeline products within the global Traumatic BrainInjury Therapeutics sector. This report is built using data and information sourced fromproprietary databases, primary and secondary research and in-house analysis byGlobalData’s team of industry expertsScopeThe report provides information on the key drivers and challenges of the Traumatic BrainInjury Therapeutics market. Its scope includes -- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan)Traumatic Brain Injury Therapeutics market revenues data from 2006 to 2011, forecast foreight years to 2019.- Pipeline analysis data providing a split across the different phases, mechanisms of actionbeing developed and emerging trends by seven key markets. Pipeline candidates fall undermajor therapeutic classes.- Analysis of the current and future competition in the seven key countries Traumatic BrainInjury Therapeutics market.- Insightful review of the key industry drivers, restraints and challenges. Each trend isindependently researched to provide a qualitative analysis of its implications.- Key topics covered include strategic competitor assessment, market characterization,unmet needs and the implications for the Traumatic Brain Injury Therapeutics market.- Analysis of key recent licensing and partnership agreements in Traumatic Brain InjuryTherapeutics marketGet more information of this report @ http://www.reportsnreports.com/reports/167922-traumatic-brain-injury-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.htmlReasons to buyThe report will enhance your decision making capability. It will allow you to -- Develop and design your in-licensing and out-licensing strategies through a review of pipeline productsand technologies and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving the global TraumaticBrain Injury Therapeutics market.- Drive revenues by understanding the key trends, innovative products and technologies, marketsegments and companies likely to impact the global Traumatic Brain Injury Therapeutics market infuture.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by
  2. 2. analyzing the performance of various competitors.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Organize your sales and marketing efforts by identifying the market categories and segments thatpresent maximum opportunities for consolidations, investments and strategic partnerships.- What’s the next big thing in the global Traumatic Brain Injury Therapeutics market landscape? –Identify, understand and capitalize.Report Details:Published: June 2012No. of Pages: 98Price: Single User License: US $ 3995 Corporate User License: US $ 11985Major points covered in Table of Contents of this report include:1 Table of Contents 31.1 List of Tables 51.2 List of Figures 72 Traumatic Brain Injury Therapeutics - Introduction 82.1 Disease Overview 82.1.1 Classification of Traumatic Brain Injury 92.1.2 Types of Traumatic Brain Injury 112.1.3 Effects of Traumatic Brain Injury 122.1.4 Post-Injury Complications Associated with Traumatic Brain Injury 132.2 Epidemiology 142.2.1 Traumatic Brain Injury: “A Silent Epidemic” in the US 162.2.2 The UK 172.2.3 Spain 172.2.4 France 172.2.5 Italy 172.2.6 Germany 172.2.7 Japan 172.2.8 Mortality 182.2.9 Quality of Life Parameters 192.2.10 Pharmacoeconomic Burden 192.3 Etiology 192.4 Pathophysiology 212.4.1 Primary Injury 212.4.2 Secondary Injury 222.4.3 Inflammatory Response 232.4.4 Repair-Regeneration 232.5 Signs and Symptoms 232.6 Diagnosis 242.6.1 Initial Measures 24
  3. 3. 2.6.2 Complete Clinical Evaluation 252.7 Treatment and Management Pattern 282.7.1 Acute Management of Traumatic Brain Injury in Hospital 282.7.2 Treatment of Mild Traumatic Brain Injury 332.7.3 Treatment of Post-Traumatic Brain Injury Complications 362.7.4 Rehabilitation 392.8 Referral Pathway 392.9 GlobalData Pipeline Report Guidance 413 Traumatic Brain Injury Therapeuctics - Market Characterization 423.1 Overview 423.2 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Global 433.3 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Global 443.4 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury – Global 453.5 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – The US 463.6 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – The US 473.7 Traumatic Brain Injury Therapeutics Market Distribution based on Severity of Injury – The US 483.8 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – France 493.9 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – France 503.10 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, France 513.11 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Germany 523.12 Traumatic Brain Injury Therapeutics Market Forecast (2011-2019) – Germany 533.13 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Germany 543.14 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Italy 553.15 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Italy 563.16 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Italy 573.17 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Spain 583.18 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Spain 593.19 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Spain 603.20 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – The UK 613.21 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – The UK 623.22 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, The UK 633.23 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Japan 643.24 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Japan 653.25 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Japan 663.26 Drivers and Barriers for Traumatic Brain Injury Therapeutics Market 673.26.1 Drivers for Traumatic Brain Injury Therapeutics Market 673.26.2 Barriers for TBI Therapeutics Market 673.27 Opportunity and Unmet Need Analysis 693.27.1 Opportunity and Unmet Need in Traumatic Brain Injury Therapeutics Market 693.28 Key Takeaway 694 Traumatic Brain Injury Therapeutics - Competitive Assessment 704.1 Overview 704.2 Strategic Competitor Assessment 704.3 Product Profile for the Major Product in the Traumatic Brain Injury Therapeutics 704.3.1 Mannitol 704.4 Key Takeaway 715 Traumatic Brain Injury Therapeutics - Pipeline Assessment 725.1 Overview 72
  4. 4. 5.2 Strategic Pipeline Assessment 725.3 Traumatic Brain Injury Therapeutics Pipeline – Pipeline by Phases of Development 735.3.1 Traumatic Brain Injury Therapeutics – Phase III Pipeline 735.3.2 Traumatic Brain Injury Therapeutics –Phase II Pipeline 735.3.3 Traumatic Brain Injury Therapeutics – Phase I/II Pipeline 745.3.4 Traumatic Brain Injury Therapeutics –Phase I Pipeline 745.3.5 Traumatic Brain Injury Therapeutics – IND Filed 745.3.6 Traumatic Brain Injury Therapeutics – Preclinical Phase 755.3.7 Traumatic Brain Injury Therapeutics – Discovery Pipeline 755.4 Technology Trends Analytic Framework 765.5 Traumatic Brain Injury Therapeutics Market –Pipeline by Mechanism of Action 785.6 Molecule Profiling for Promising Drug under Clinical development 795.6.1 BHR-100 795.7 Key Takeaway 806 Traumatic Brain Injury Therapeutics - Clinical Trials Mapping 816.1 Clinical Trials by Region/ Country 816.2 Clinical Trials by Phase 826.3 Clinical Trials by Trial Status 836.4 Top 10 companies participating in Therapeutics Clinical Trials 846.5 Prominent Sponsors 857 Traumatic Brain Injury Therapeutics - Strategic Assessment 877.1 Key Events Impacting the Future Traumatic Brain Injury Market 877.2 Implications for Future Traumatic Brain Injury Market Competition 888 Traumatic Brain Injury Therapeutics - Future Players 898.1 Introduction 898.2 Company Profiles 898.2.1 BHR Pharma, LLC 899 Traumatic Brain Injury Therapeutics - Appendix 909.1 Market Definitions 909.2 Abbreviations 909.3 Bibliography 919.4 Research Methodology 939.4.1 Coverage 939.4.2 Secondary Research 949.4.3 Primary Research 949.4.4 Modelling and Forecasting 949.4.5 Expert Panel Validation 979.5 Contact Us 979.6 Disclaimer 98Related Reports @ http://www.reportsnreports.com/publisher/globaldata/Contact:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.Tel: + 1 888 391 5441
  5. 5. sales@reportsandreports.comConnect With Us:

×